Latest Headlines

  1. MEDITECH Introduces Expanse Outreach Portal To Support Laboratory Clients 2/26/2025

    MEDITECH today announced the addition of a new web-based Expanse Outreach Portal.

  2. Visby Medical™Receives FDA Clearance And CLIA Waiver For Point-Of-Care Respiratory Health Test 2/26/2025

    Visby Medical™ announced today that it has received 510(k) clearance and was granted a CLIA waiver from the U.S. Food and Drug Administration (FDA) for its point-of-care respiratory health test.

  3. Oklo Collaborates With The U.S. DOE And Oak Ridge National Laboratory To Advance Next Generation Materials Development 2/25/2025

    Oklo Inc. (NYSE: OKLO) (“Oklo”), an advanced nuclear technology company, has announced its participation in the U.S. Department of Energy (DOE) Voucher Program, which is expected to support the evaluation and testing of advanced structural materials for Oklo’s Aurora powerhouse.

  4. CytoChip Receives FDA Clearance And First CLIA Waiver For A Cartridge-Based Complete Blood Count Test 2/25/2025

    CytoChip proudly announces that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance and a CLIA Waiver for its CitoCBC, making it the first cartridge-based CBC test to achieve this milestone.

  5. Elemental Machines And eLabNext Partner To Launch Free Add-On To Monitor And Record Environmental Laboratory Data 2/24/2025

    Elemental Machines and eLabNext announced today that the Elemental Machines’ Connector add-on will now be available for free in the eLabMarketplace, eLabNext’s application library for extending and personalizing the functionality of their Digital Lab Platform.

  6. Labcorp Announces Clinical Availability Of Liquid Biopsy Test To Guide Personalized Treatment Plans For Patients With Advanced Solid Tumors 2/24/2025

    Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the clinical availability of Labcorp® Plasma CompleteTM, a circulating tumor DNA (ctDNA)-based comprehensive genomic profiling solution for patients with advanced solid tumors.

  7. Fresenius Medical Care Announces Divestment Of Select Laboratory Assets To Quest Diagnostics 2/24/2025

    Fresenius Medical Care (XETRA: FME; NYSE: FMS), the world's leading provider of products and services for individuals with renal disease, and Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced that, under terms of a definitive acquisition agreement, Quest will acquire select assets of FME's wholly owned Spectra Laboratories, a leading provider of renal-specific laboratory testing services in the U.S.

  8. AccessDx Laboratory Announces Integration With PointClickCare 2/19/2025

    AccessDx Laboratory, a nationwide provider of precision medicine and diagnostics solutions, today announced its expanded integration with PointClickCare, a leading healthcare technology platform enabling meaningful care collaboration and real-time patient insights.

  9. Amplified Sciences Eearns CLIA Certification For Its First Test To Assess Pancreatic Cancer Risk 2/19/2025

    Amplified Sciences, a clinical-stage life sciences diagnostic company that develops tests for early, more accurate detection of challenging diseases, starting with pancreatic cancer, has received regulatory clearance under the federal Clinical Laboratory Improvement Amendments (CLIA) program for its first product, PanCystPro™.

  10. Pretorian Labs To Test Human Patients For H5N1 (Bird Flu) 2/19/2025

    Pretorian Labs, LLC. is one of the first laboratories in the US to test human patients for H5N1 virus (Bird Flu). This test is now available to all providers and facilities nationally who are existing or new clients of Pretorian Labs.